De Burlo Group’s Celgene Corp CELG Stock Holding History

De Burlo Group’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-18,150	Closed	-$2.17M	–	108
2015 Q4	$2.17M	Sell	18,150 -29,600	-62%	-$3.42M	0.51%	56
2015 Q3	$5.17M	Buy	47,750 +12,000	+34%	+$1.49M	1.21%	39
2015 Q2	$4.14M	Sell	35,750 -7,900	-18%	-$903K	0.87%	46
2015 Q1	$5.03M	Buy	43,650 +5,150	+13%	+$615K	1%	44
2014 Q4	$4.31M	Buy	+38,500	New	+$4.06M	0.87%	51
2014 Q2	–	Sell	-51,000	Closed	-$3.56M	–	111
2014 Q1	$3.56M	Sell	51,000 -38,800	-43%	-$3.07M	0.86%	48
2013 Q4	$7.59M	Buy	+89,800	New	+$7.11M	1.81%	18

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

De Burlo Group's CELG Position: Q1 2016 in Review

De Burlo Group sold out of Celgene Corp (CELG) in Q1 2016, closing a stake of 18,150 shares — an estimated $2.17M sold.

De Burlo Group first reported a position in CELG in Q4 2013 and held it in 7 quarters. The position peaked at $7.59M in Q4 2013. 1,224 funds tracked by Wall St. Rank hold CELG as of Q1 2016.

De Burlo Group reported no remaining Celgene Corp position as of Q1 2016 after selling out during the quarter.
De Burlo Group sold 18,150 Celgene Corp shares in Q1 2016, an estimated $2.17M.
De Burlo Group first reported a position in Celgene Corp in Q4 2013 and held it in 7 quarters.
De Burlo Group's Celgene Corp position peaked at $7.59M in Q4 2013.
1,224 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2016.

Based on De Burlo Group's 13F filing for Q1 2016, filed 5 May 2016.